Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KPTI

Karyopharm

$18.50

0.47 (2.61%)

, VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.50

0.47 (2.61%)

VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

VRNA

Verona Pharma

$13.10

-0.3 (-2.24%)

AVRO

AvroBio

$40.52

-0.08 (-0.20%)

ASND

Ascendis Pharma

$67.70

-0.8 (-1.17%)

OBSV

ObsEva

$12.98

-1.02 (-7.29%)

OMER

Omeros

$20.63

1.45 (7.56%)

NVCR

Novocure

$36.85

-0.1 (-0.27%)

XNCR

Xencor

$40.97

0.28 (0.69%)

PRTK

Paratek Pharmaceuticals

$10.10

0.45 (4.66%)

MGTA

Magenta Therapeutics

$12.99

0.09 (0.70%)

CRVS

Corvus Pharmaceuticals

$9.03

-0.4 (-4.24%)

AKAO

Achaogen

$5.66

-0.165 (-2.84%)

ALBO

Albireo Pharma

$31.77

0.17 (0.54%)

EIGR

Eiger BioPharmaceuticals

$10.05

0.375 (3.88%)

STML

Stemline

$15.40

0.25 (1.65%)

SRRA

Sierra Oncology

$1.95

-0.11 (-5.34%)

ABUS

Arbutus Biopharma

$9.20

-0.45 (-4.66%)

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

SRRK

Scholar Rock

$14.00

0.71 (5.34%)

ARGX

Argenx

$87.50

0.19 (0.22%)

ALNA

Allena Pharmaceuticals

$10.98

0.11 (1.01%)

KURA

Kura Oncology

$19.75

-0.2 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

Tuesday
KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

, VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

09:08
08/14/18
08/14
09:08
08/14/18
09:08
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

VRNA

Verona Pharma

$13.40

-0.47 (-3.39%)

AVRO

AvroBio

$40.60

0.61 (1.53%)

ASND

Ascendis Pharma

$68.50

0.82 (1.21%)

OBSV

ObsEva

$14.00

-0.96 (-6.42%)

OMER

Omeros

$19.18

1.41 (7.93%)

NVCR

Novocure

$36.95

1 (2.78%)

XNCR

Xencor

$40.69

0.38 (0.94%)

PRTK

Paratek Pharmaceuticals

$9.65

-0.4 (-3.98%)

MGTA

Magenta Therapeutics

$12.90

-0.16 (-1.23%)

CRVS

Corvus Pharmaceuticals

$9.43

0.12 (1.29%)

AKAO

Achaogen

$5.82

-0.35 (-5.67%)

ALBO

Albireo Pharma

$31.60

0.42 (1.35%)

EIGR

Eiger BioPharmaceuticals

$9.68

0.025 (0.26%)

STML

Stemline

$15.15

0.15 (1.00%)

SRRA

Sierra Oncology

$2.06

(0.00%)

ABUS

Arbutus Biopharma

$9.65

0.15 (1.58%)

MRSN

Mersana Therapeutics

$12.71

-0.205 (-1.59%)

SRRK

Scholar Rock

$13.29

-1.11 (-7.71%)

ARGX

Argenx

$87.31

-2.79 (-3.10%)

ALNA

Allena Pharmaceuticals

$10.87

0.13 (1.21%)

KURA

Kura Oncology

$19.95

0.95 (5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

Monday
STML

Stemline

$15.00

0.1 (0.67%)

08:16
08/13/18
08/13
08:16
08/13/18
08:16
Conference/Events
Stemline to hold a conference all »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 14

    Aug

STML

Stemline

$15.00

0.1 (0.67%)

06:34
08/13/18
08/13
06:34
08/13/18
06:34
Hot Stocks
Stemline: FDA accepts ELZONRIS BLA, grants Priority Review »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

Over a week ago
STML

Stemline

$14.25

-0.2 (-1.38%)

08:09
08/09/18
08/09
08:09
08/09/18
08:09
Earnings
Stemline reports Q2 EPS (66c), consensus (64c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

Over a month ago
STML

Stemline

$16.55

-0.6 (-3.50%)

07:09
06/25/18
06/25
07:09
06/25/18
07:09
Hot Stocks
Stemline completes rolling BLA submission for ELZONRIS »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$17.95

-0.4 (-2.18%)

07:28
06/12/18
06/12
07:28
06/12/18
07:28
Initiation
Stemline initiated at Roth Capital »

Stemline initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$19.55

-0.1 (-0.51%)

07:13
06/05/18
06/05
07:13
06/05/18
07:13
Hot Stocks
Stemline announces 'positive' presentations of SL-801, SL-701 at ASCO »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
STML

Stemline

$19.25

(0.00%)

07:25
05/17/18
05/17
07:25
05/17/18
07:25
Hot Stocks
Stemline to present SL-801, SL-701 clinical data at ASCO »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$18.25

0.5 (2.82%)

16:01
05/09/18
05/09
16:01
05/09/18
16:01
Earnings
Stemline reports Q1 EPS (69c), consensus (69c) »

Stemline ended Q1 with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.